ALTHERA
Pharmaceuticals, 89 Headquarters Plz, Morristown, New Jersey, 07960, Je, 11-50 Employees
Who is ALTHERA
Delivering innovative therapeutic options to improve heart health. Founded in 2010, Althera develops innovative patient focused medicines to improve cardiovascular health. Our first produ...
Read More
-
Headquarters: 89 Headquarters Plz, Morristown, New Jersey, 07960, Je
-
Date Founded: 2010
-
Employees: 11-50
-
Revenue: 1 Million to 5 Million
-
Active Tech Stack: See technologies
-
CEO:
Sanjeev Agarwal
Email
Phone
Industry: Pharmaceuticals
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
View Employees
Althera Org Chart and Mapping
Similar Companies to Althera
1623 Studios
-
11-50
-
$ 1 Million to 5 Million
Ohm Pharma, Inc.
-
11-50
-
$ 1 Million to 5 Million
Orbis Biosciences
-
11-50
-
$ 1 Million to 5 Million
Althera Activity Score
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Althera
Answer: Althera's headquarters are located at 89 Headquarters Plz, Morristown, New Jersey, 07960, Je
Answer: Althera's official website is https://altherainc.com
Answer: Althera's revenue is 1 Million to 5 Million
Answer: Althera's SIC: 2834
Answer: Althera's NAICS: 325412
Answer: Althera has 11-50 employees
Answer: Althera is in PHARMACEUTICALS
Answer: Althera top competitors include: Delta Pharma Limited, 1623 Studios, Redlers Long Term Care Pharmacy, Orbis Biosciences, Spear Pharmaceuticals, Antaros Medical, Ohm Pharma, Inc., Global Pricing Innovations (Gpi), Shield Therapeutics, Navamedic Asa, Stason Pharmaceuticals of Texas
Answer: Althera contact info: Phone number: ********** Website: https://altherainc.com
Answer: Delivering innovative therapeutic options to improve heart health. Founded in 2010, Althera develops innovative patient focused medicines to improve cardiovascular health. Our first product Rosuvastatin/Ezetimibe (AL-320) is available to patients in more than 28 countries worldwide including all major European markets. Althera’s second product Ezetimibe/Atorvastatin tablets (AL-310), is approved in both US and Europe, and is expected to be available to patients in 2021.
Answer:
Premium Sales Data for Prospecting
- Sales data across over 200M records
- Up-to-date records (less decayed data)
- Accurate Email Lists (real-world tested)
- Powerful search engine and intuitive interface
Get Full Access
View Employees
Althera Activity Score
Sign in to CIENCE GO Data to uncover contact details
Free credits every month